Lupin got USFDA approval for Desoximetasone topical spray
The company has received final approval for its Desoximetasone Topical Spray, 0.25%, 30 ml, 50 ml, and 100 ml from the United States Food and Drug Administration (USFDA) to market a generic version of Taro Pharmaceuticals USA Inc.’s Topicort Topical Spray, 0.25%.
Desoximetasone Topical Spray is the generic equivalent of Taro Pharmaceuticals USA Inc.’s Topicort Topical Spray, 0.25%.
